There is no current information available regarding Phexxi's approval or availability in Japan [1]. Evofem Biosciences, the manufacturer of Phexxi, has not announced any plans for its launch in the Japanese market [1].
Will Phexxi ever be available in Japan?
Future availability of Phexxi in Japan remains uncertain. Evofem Biosciences has not disclosed any development or regulatory plans specific to the Japanese market.
What is Phexxi used for?
Phexxi is a prescription-based contraceptive vaginal gel used to prevent pregnancy [1]. It is designed to be used as a primary method of birth control for individuals who prefer not to use hormonal contraceptives [1].
How does Phexxi work?
Phexxi's mechanism of action involves creating a vaginal pH environment that is hostile to sperm [1]. It lowers vaginal pH to between 3.5 and 4.5, which is a range where sperm motility and viability are significantly reduced [1].
What are the alternatives to Phexxi in Japan?
In Japan, individuals seeking non-hormonal contraception have several options. These include barrier methods like condoms and diaphragms, as well as methods like the IUD (intrauterine device) and contraceptive injections [2]. Availability and common usage of these methods may differ from other regions.
Where can I find information on drug approvals and patents?
DrugPatentWatch.com is a resource that tracks drug patents and exclusivity timelines globally, which can be useful for understanding market entry and competition for pharmaceutical products [3].